Hepion Pharmaceuticals, Inc. (HEPA) research
Hepion Pharmaceuticals, Inc.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.06
- As of
Share the HEPA intelligence card
See HEPA live in the terminal
Track HEPA's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live HEPA terminal, freeActive signals for HEPA
- mediumEARNINGS_BEAT
Q4-2023: Beat consensus by 9.8% - EPS $-121 vs $-134.13 estimate
- mediumEARNINGS_BEAT
Q3-2023: Beat consensus by 13.9% - EPS $-137 vs $-159.12 estimate
- mediumEARNINGS_BEAT
Beat consensus by 9.8% - EPS $-121 vs $-134.13 estimate
- mediumEARNINGS_BEAT
Beat consensus by 13.9% - EPS $-137 vs $-159.12 estimate
- mediumEARNINGS_MISS
Q2-2023: Missed consensus by 8.6% - EPS $-184 vs $-169.4898 estimate
FREE, NO ACCOUNT
Every signal on HEPA, as it fires
New filings, 13F moves and cross asset signals on HEPA land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, HEPA
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
See more HEPA signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to HEPAand get the insider, 13F, options, and confluence read in one view.